Michael S. Diamond
Diamond, Michael S.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 81805615 (Personal)
Permalink: http://viaf.org/viaf/81805615
Preferred Forms
-
100 1 _
‡a
Diamond, Michael S.
-
100 1 _
‡a
Diamond, Michael S.
-
100 1 _
‡a
Diamond, Michael S.
-
100 1 _
‡a
Diamond, Michael S.
-
100 1 _
‡a
Diamond, Michael S.
-
100 1 _ ‡a Diamond, Michael S.
-
100 1 _ ‡a Diamond, Michael S.
-
100 1 _ ‡a Diamond, Michael S. (sparse)
-
100 1 _ ‡a Diamond, Michael S.
-
100 0 _
‡a
Michael S. Diamond
4xx's: Alternate Name Forms (3)
5xx's: Related Names (3)
- 510 2 _
‡a
School of Medicine (Saint Louis, Mo.)
- 510 2 _
‡a
School of Medicine
‡9
g:Saint Louis, Mo.
‡e
Affiliation
- 551 _ _
‡a
St. Louis, Mo.
Works
| Title | Sources |
|---|---|
| Emergency management of infectious diseases, 2008: |
|
| Influenza virus usurps an interferon-induced translational program to promote viral replication |
|
| Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice |
|
| Negative regulators of the RIG-I-like receptor signaling pathway |
|
| Neurotropic arboviruses induce interferon regulatory factor 3-mediated neuronal responses that are cytoprotective, interferon independent, and inhibited by Western equine encephalitis virus capsid |
|
| Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity |
|
| Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice |
|
| A novel computer algorithm improves antibody epitope prediction using affinity-selected mimotopes: a case study using monoclonal antibodies against the West Nile virus E protein |
|
| Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections |
|
| Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells |
|
| Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene |
|
| Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity |
|
| Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence |
|
| Pattern recognition receptor MDA5 modulates CD8+ T cell-dependent clearance of West Nile virus from the central nervous system |
|
| A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions |
|
| A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection |
|
| Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection |
|
| The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus |
|
| Resistance to Alpha/Beta Interferon Is a Determinant of West Nile Virus Replication Fitness and Virulence |
|
| Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. |
|
| The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness |
|
| RIG-I Signaling Is Essential for Influenza B Virus-Induced Rapid Interferon Gene Expression |
|
| RNA sensor-induced type I IFN prevents diabetes caused by a β cell-tropic virus in mice |
|
| Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce |
|
| S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3. |
|
| The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters |
|
| SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function |
|
| Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E |
|
| Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin-Mediated Neutralization |
|
| Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection |
|
| Sensitive population profiling and genome assembly of HIV and Flaviviruses using ultra-deep sequencing technologies. |
|
| A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage |
|
| A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis |
|
| Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses |
|
| The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection |
|
| Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization |
|
| Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants |
|
| Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope |
|
| Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope |
|
| Structural basis of Flavivirus NS1 assembly and antibody recognition |
|
| Structural study of the C-terminal domain of non-structural protein 1 from Japanese encephalitis virus. |
|
| Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. |
|
| Structure, expression, and intracellular localization of the SARS-CoV accessory proteins 7a and 7b. |
|
| Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers |
|
| The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity |
|
| TAM Receptors Are Not Required for Zika Virus Infection in Mice |
|
| A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection |
|
| A tetravalent dengue nanoparticle stimulates antibody production in mice |
|
| Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques |
|
| Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]. |
|
| Therapeutic efficacy of favipiravir against Bourbon virus in mice. |
|
| Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants |
|
| TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis |
|
| Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection |
|
| Translation efficiency determines differences in cellular infection among dengue virus type 2 strains |
|
| The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex |
|
| Tregs control the development of symptomatic West Nile virus infection in humans and mice |
|
| Tumor Necrosis Factor Alpha Protects against Lethal West Nile Virus Infection by Promoting Trafficking of Mononuclear Leukocytes into the Central Nervous System |
|
| Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes |
|
| Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms |
|
| Understanding How Zika Virus Enters and Infects Neural Target Cells |
|
| The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses |
|
| Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection |
|
| Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge |
|
| Vaccine Development as a Means to Control Dengue Virus Pathogenesis: Do We Know Enough? |
|
| Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus |
|
| Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease |
|
| Vaccines in 2017: Closing in on a Zika virus vaccine |
|
| A viral RNA structural element alters host recognition of nonself RNA |
|
| WDFY4 is required for cross-presentation in response to viral and tumor antigens |
|
| West Nile encephalitis virus infection viral pathogenesis and the host immune response |
|
| West Nile virus: crossing the blood-brain barrier |
|
| West Nile virus. II. Immunopathophysiology in humans |
|
| West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody |
|
| West Nile virus–induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons |
|
| West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response |
|
| West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H |
|
| Zika Virus Causes Acute and Chronic Prostatitis in Mice and Macaques |
|
| Zika Virus Causes Acute Infection and Inflammation in the Ovary of Mice Without Apparent Defects in Fertility |
|
